Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Molecular Genetics Studies of Cancer Patients and Their Relatives

NCT ID: NCT04185935Sponsor: City of Hope Medical CenterLast updated: 2025-06-25

Summary

This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.

Detailed description

PRIMARY OBJECTIVES: I. To identify rare cancer patients and families in whom the pattern of disease suggests a genetic susceptibility to cancer or other etiology suggestive of a carcinogenic exposure and to characterize the underlying predisposition. II. To determine the contribution of heredity (genotype) and biomarkers to clinical outcome (phenotype, occurrence of new cancers, prognosis and quality of life) in subgroups of cancer patients with and without clinical high-risk features. OUTLINE: Patients may provide a sample of blood, a saliva sample, a sample of eyebrow plucks, a sample of urine, and/or stored tumor or healthy tissue.

Arms & interventions

  • OtherBiospecimen Collection

    Provide a sample of blood, a saliva sample, a sample of eyebrow plucks, a sample of urine, and/or stored tumor or healthy tissue

  • OtherQuestionnaire Administration

    Ancillary studies

Outcome measures

Primary

  • Cancer risk assessment

    Time frame: Up to 10 years

  • Exploratory biomarkers for future studies

    Time frame: Up to 10 years

Eligibility criteria

Sex: AllAge: All agesHealthy volunteers: Yes
Inclusion Criteria: * Individuals must have a personal history of cancer and/or a family history of cancer suggestive of the presence of an inherited predisposition. This inherited predisposition might manifest as: * Young age cancer diagnosis * Multiple primary neoplasms in affected member * The presence of rare tumor types in the family * Congenital malformations * Any other family clustering of cancer * Any other cancer-predisposing genetic diseases/conditions * Individuals may also be eligible by participation in the City of Hope Cancer Screening \& Prevention Program Network (CSPPN) clinical service or on the basis of membership in a group known or suspected to have an increased risk of carrying a genetic alteration or of sustaining a particular exposure that would place that at increased risk of cancer. (Examples would include members of occupational cohorts like asbestos workers, individuals with multiple dysplastic nevi in the absence of a family history of cancer, and individuals descended from a particular tribe in the American Southwest who have an increased incidence of a rare genetic alteration associated with an increased risk of a specific cancer.) * Individuals and families may be referred to us in a number of different ways. After initial contact is made with a individual or family by family studies personnel; an individual within the bloodline will be identified as the historian. There may be more than one historian within a family * At least one historian must be wiling to provide information or access as needed to contact appropriate family members for documentation of cancer and for consent. An individual is considered to be eligible to participate if they criteria; contact with relatives is not always indicated * Individuals who are under 18 are eligible for study if they meet the criteria. Consent for participation must be given by a legal guardian or parent * Deceased patients may be included in the study. Public records, such as death certificates, can be used to confirm information from individuals or family members. If medical records are needed, consent for these records will be obtained from the deceased's next of kin. Next of kin refers to the following hierarchy of relatives; spouse, offspring, parents, and siblings. (Any further use of next of kin in this protocol should relate back to this hierarchy.) Archived tissue samples, such as pathology blocks or snap frozen tumor from a pathology department tumor bank (discard specimens) may be used for genetic research Exclusion Criteria: * A family may be ineligible for study if the historian will not allow access to anyone within the family and thus, the accuracy of the family history cannot be established

Study locations (35)

Valleywise Comprehensive Health Center - Phoenix

Phoenix, Arizona, 85008

Recruiting
Ian K. Komenaka · Contact
Ian K. Komenaka · Principal Investigator

John Muir Medical Center-Concord Campus

Concord, California, 94520

Recruiting
Shellie Campos · Principal Investigator

City of Hope Medical Center

Duarte, California, 91010

Recruiting
Jeffrey N. Weitzel · Contact
Jeffrey N. Weitzel · Principal Investigator

Saint Jude Medical Center

Fullerton, California, 92835

Recruiting
William E. Lawler · Contact
William E. Lawler · Principal Investigator

Saddleback Memorial Medical Center

Laguna Hills, California, 92653

Recruiting
Jeffrey N. Weitzel · Contact
Jeffrey N. Weitzel · Principal Investigator

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033

Recruiting
Charite Ricker · Principal Investigator

Saint Joseph Hospital - Orange

Orange, California, 92868

Recruiting
Jeffrey N. Weitzel · Contact
Jeffrey N. Weitzel · Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

Roseville, California, 95661

Recruiting
Kristie A. Bobolis · Contact
Kristie A. Bobolis · Principal Investigator

Cancer Center of Santa Barbara

Santa Barbara, California, 93105

Recruiting
Frederic C. Kass · Contact
Frederic C. Kass · Principal Investigator

Lynn Regional Cancer Center - West

Boca Raton, Florida, 33428

Recruiting
Louise E. Morrell · Contact
Louise E. Morrell · Principal Investigator

Holy Cross Hospital

Fort Lauderdale, Florida, 33308

Recruiting
Zdenka E. Segota · Contact
Zdenka E. Segota · Principal Investigator

Kootenai Cancer Center

Post Falls, Idaho, 83854

Recruiting
Jeffrey W. Allen · Contact
Jeffrey W. Allen · Principal Investigator

John H Stroger Jr Hospital of Cook County

Chicago, Illinois, 60612

Recruiting
Pamela Ganschow · Contact
Pamela Ganschow · Principal Investigator

Rush University Medical Center

Chicago, Illinois, 60612

Recruiting
Lydia Usha · Contact
Lydia Usha · Principal Investigator

Mercy Hospital

Cedar Rapids, Iowa, 52403

Recruiting
Amie Hass · Principal Investigator

Suburban Hospital

Bethesda, Maryland, 20814

Recruiting
Carolyn B. Hendricks · Contact
Carolyn B. Hendricks · Principal Investigator

Frederick Oncology Hematology Associates

Frederick, Maryland, 21702

Recruiting
Patricia A. Rice · Contact
Patricia A. Rice · Principal Investigator

Steward Saint Elizabeth's Medical Center

Brighton, Massachusetts, 02135

Recruiting
Beth B. Herrick · Contact
Beth B. Herrick · Principal Investigator

Hunterdon Medical Center

Flemington, New Jersey, 08822

Recruiting
Kenneth B. Blankstein · Contact
Kenneth B. Blankstein · Principal Investigator

Lovelace Medical Center-Downtown

Albuquerque, New Mexico, 87102

Recruiting
Malcolm H. Purdy · Principal Investigator

New Mexico Oncology Hematology Consultants

Albuquerque, New Mexico, 87109

Recruiting
Annette C. Fontaine · Contact
Annette C. Fontaine · Principal Investigator

Presbyterian Kaseman Hospital

Albuquerque, New Mexico, 87110

Recruiting
Kenneth J. Smith · Contact
Kenneth J. Smith · Principal Investigator

Mount Kisco Medical Group at Northern Westchester Hospital

Mount Kisco, New York, 10549-3417

Recruiting
Nancy Cohen · Contact
Nancy Cohen · Principal Investigator

Health Quest Medical Practice PC-Cardio Thoracic

Poughkeepsie, New York, 12601

Recruiting
Jonathan Clyman · Contact
Jonathan Clyman · Principal Investigator

Aultman Health Foundation

Canton, Ohio, 44710

Recruiting
Shruti Trehan · Principal Investigator

Saint Charles Health System

Bend, Oregon, 97701

Recruiting
Coralia B. Calomeni · Principal Investigator

Paoli Memorial Hospital

Paoli, Pennsylvania, 19301

Recruiting
Michael B. Dabrow · Contact
Michael B. Dabrow · Principal Investigator

Reading Hospital

West Reading, Pennsylvania, 19611

Recruiting
Terrence P. Cescon · Contact
Terrence P. Cescon · Principal Investigator

The Don and Sybil Harrington Cancer Center

Amarillo, Texas, 79106

Recruiting
Anita Ravipati · Contact
Anita Ravipati · Principal Investigator

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, 77030

Not Yet Recruiting
April D. Sorrell · Contact
April D. Sorrell · Principal Investigator

Doctor's Hospital of Laredo

Laredo, Texas, 78041

Recruiting
Gary W. Unzeitig · Contact
Gary W. Unzeitig · Principal Investigator

Covenant Medical Center

Lubbock, Texas, 79410

Recruiting
Isaac Tafur · Contact
Isaac Tafur · Principal Investigator

Saint Agnes Hospital/Agnesian Cancer Center

Fond du Lac, Wisconsin, 54935

Recruiting
Michael W. Jones · Contact
Michael W. Jones · Principal Investigator

ProHealth Waukesha Memorial Hospital

Waukesha, Wisconsin, 53188

Recruiting
Christopher R. Hake · Contact
Christopher R. Hake · Principal Investigator

Cheyenne Regional Medical Center-West

Cheyenne, Wyoming, 82001

Recruiting
Jennifer Van Horn · Contact
Jennifer Van Horn · Principal Investigator